ANDA litigation : strategies and tactics for pharmaceutical patent litigators / Kenneth L. Dorsney, editor-in-chief.
Colaborador(es): Dorsney, Kenneth L [editor.] | American Bar Association. Section of Intellectual Property Law [sponsoring body.]
Tipo de material:![Texto](/opac-tmpl/lib/famfamfam/BK.png)
Tipo de ítem | Biblioteca actual | Colección | Signatura | Estado | Fecha de vencimiento | Código de barras |
---|---|---|---|---|---|---|
![]() |
Biblioteca Digital UIN | VLEX | Disponible | 40482 |
Includes bibliographical references and index.
The statutory and regulatory scheme -- The drug approval process--an overview -- Notice and prefiling considerations -- The litigation timeline -- Initiating litigation -- Use of reissue proceedings in Hatch-Waxman litigation -- Inter partes review in ANDA litigation -- Examining subject-matter jurisdiction over declaratory judgment claims filed in combination with patent infringement claims under section 271(e)(2)(a) -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Posttrial -- Appeals to the Court of Appeals for the Federal Circuit -- Hatch-Waxman practice in the Supreme Court of the United States -- Managing an ANDA litigation -- Pharmaceutical regulation and litigation in foreign countries.
No hay comentarios en este titulo.